Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of antiviral and anticancer agents. The presence of the fluorocyclopropyl group enhances metabolic stability and bioavailability in drug candidates. It is commonly employed in medicinal chemistry for constructing chiral building blocks where the tert-butyl carbamate (Boc) group acts as a protecting group for amines, enabling selective reactions in multi-step syntheses. Its stereochemistry supports the preparation of enantiomerically pure compounds, important for optimizing biological activity and reducing off-target effects in drug design.